Search
Kalaris Therapeutics Inc
KLRSAdd to Watchlist
4.750USD
+0.220+4.86%
Close 07/02, 13:00（ET）Quotes delayed by 15 min
113.01MMarket Cap
LossP/E TTM
Revenue Breakdown
FY2021
FY2020
FY2019
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
0.00
0.00%
By Business
By Region
Relevant data have not been disclosed by the company yet.